Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice

Virology

Volumn 403, Issue 2, 2010, Pages 128-136

  Hufbauer, M ^a   Lazi, D ^a   Akgul B ^a   Brandsma, J L ^b   Pfister, H ^a   Weissenborn, S J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human papillomavirus; Skin tumors; Skin wounds; Transgenic mice; UV irradiation

Indexed keywords

BETA ACTIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; PROTEIN E6; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN PAPILLOMAVIRUS TYPE 8; INCIDENCE; MOUSE; NONHUMAN; ONCOGENE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN IRRITATION; SKIN PAPILLOMA; TRANSGENIC MOUSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; WART VIRUS;

ANIMALS; BETAPAPILLOMAVIRUS; HUMANS; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS; VIRULENCE FACTORS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 8; MUS MUSCULUS;

EID: 77953360695     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.013     Document Type: Article

References (33)

1. Akgül B., Lemme W., Garcia-Escudero R., Storey A., Pfister H.J. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch. Virol. 2005, 150(1):145-151.
2. Akgül B., Cooke J.C., Storey A. HPV-associated skin disease. J. Pathol. 2006, 208(2):165-175.
3. Akgül B., Ghali L., Davies D., Pfister H., Leigh I.M., Storey A. HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Exp. Dermatol. 2007, 16(7):590-599.
4. Alam M., Ratner D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 2001, 344(13):975-983.
5. Antonsson A., Karanfilovska S., Lindqvist P.G., Hansson B.G. General acquisition of human papillomavirus infections of skin occurs in early infancy. J. Clin. Microbiol. 2003, 41(6):2509-2514.
6. Bouwes Bavinck J.N., Stark S., Petridis A.K., Marugg M.E., Ter Schegget J., Westendorp R.G., Fuchs P.G., Vermeer B.J., Pfister H. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses. Br. J. Dermatol. 2000, 142(1):103-109.
7. Burke K., Wei H. Synergistic damage by UVA radiation and pollutants. Toxicol. Ind. Health 2009, 25(4-5):219-224.
8. Coussens L.M., Hanahan D., Arbeit J.M. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 1996, 149(6):1899-1917.
9. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324(1):17-27.
10. Dell'Oste V., Azzimonti B., De Andrea M., Mondini M., Zavattaro E., Leigheb G., Weissenborn S.J., Pfister H., Michael K.M., Waterboer T., Pawlita M., Amantea A., Landolfo S., Gariglio M. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J. Invest. Dermatol. 2009, 129(4):1026-1034.
11. DePinho R.A. The age of cancer. Nature 2000, 408(6809):248-254.
12. Feltkamp M.C., Broer R., di Summa F.M., Struijk L., van der Meijden E., Verlaan B.P., Westendorp R.G., ter Schegget J., Spaan W.J., Bouwes Bavinck J.N. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res. 2003, 63(10):2695-2700.
13. Harwood C.A., Proby C.M. Human papillomaviruses and non-melanoma skin cancer. Curr. Opin. Infect. Dis. 2002, 15(2):101-114.
14. Jablonska S., Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr. Top. Microbiol. Immunol. 1994, 186:157-175.
15. Kinouchi M., Takahashi H., Itoh Y., Ishida-Yamamoto A., Iizuka H. Ultraviolet B irradiation increases keratin 5 and keratin 14 expression through epidermal growth factor receptor of SV40-transformed human keratinocytes. Arch. Dermatol. Res. 2002, 293(12):634-641.
16. Lademann J., Jacobi U., Surber C., Weigmann H.J., Fluhr J.W. The tape stripping procedure-evaluation of some critical parameters. Eur. J. Pharm. Biopharm. 2009, 72(2):317-323.
17. Layzer J.M., McCaffrey A.P., Tanner A.K., Huang Z., Kay M.A., Sullenger B.A. In vivo activity of nuclease-resistant siRNAs. RNA 2004, 10(5):766-771.
18. Leiter U., Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv. Exp. Med. Biol. 2008, 624:89-103.
19. Majewski S., Jablonska S., Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin. Dermatol. 1997, 15(3):321-334.
20. Marcuzzi G.P., Hufbauer M., Kasper H.U., Weissenborn S.J., Smola S., Pfister H. Spontaneous tumor development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J. Gen. Virol. 2009.
21. Masini C., Fuchs P.G., Gabrielli F., Stark S., Sera F., Ploner M., Melchi C.F., Primavera G., Pirchio G., Picconi O., Petasecca P., Cattaruzza M.S., Pfister H.J., Abeni D. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch. Dermatol. 2003, 139(7):890-894.
22. Nishina K., Unno T., Uno Y., Kubodera T., Kanouchi T., Mizusawa H., Yokota T. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol. Ther. 2008, 16(4):734-740.
23. Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin. Immunol. 2006, 18(6):362-374.
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
25. Pfefferle R., Marcuzzi G.P., Akgul B., Kasper H.U., Schulze F., Haase I., Wickenhauser C., Pfister H. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J. Invest. Dermatol. 2008, 128(9):2310-2315.
26. Pfister H. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 2003, (31):52-56.
27. Pfister H., Ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin. Dermatol. 1997, 15(3):335-347.
28. Rossiter H., Beissert S., Mayer C., Schon M.P., Wienrich B.G., Tschachler E., Kupper T.S. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res. 2001, 61(9):3619-3626.
29. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., Kasper H.U., Dries V., Smyth N., Fuchs P., Pfister H. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 2005, 65(4):1394-1400.
30. Sethi N., Palefsky J. Transcriptional profiling of dysplastic lesions in K14-HPV16 transgenic mice using laser microdissection. FASEB J. 2004, 18(11):1243-1245.
31. Weissenborn S.J., De Koning M.N., Wieland U., Quint W.G., Pfister H.J. Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J. Virol. 2009, 83(2):811-816.
32. Weissenborn S.J., Neale R., de Koning M.N., Waterboer T., Abeni D., Bouwes Bavinck J.N., Wieland U., Pfister H.J. Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input. J. Virol. Methods 2009, 161(2):280-283.
33. Zhang P., Nouri M., Brandsma J.L., Iftner T., Steinberg B.M. Induction of E6/E7 expression in cottontail rabbit papillomavirus latency following UV activation. Virology 1999, 263(2):388-394.